My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

24.21 -0.07 (-0.29%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

30 31 Next >

Teva Pharma's Stock Soars On Q2 Profit Beat, Highlights Strong Growth From Austedo ↗

August 02, 2023

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q2 sales reached $3.88 billion, up 2% Y/Y (4% on constant currency), slightly beating the

Via Benzinga

Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise ↗

August 02, 2023

The company also raised the lower boundary of its guidance for full-year sales.

Via Investor's Business Daily

Teva Reports Second Quarter 2023 Financial Results

August 02, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development

July 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List ↗

July 26, 2023

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

Via Benzinga

3 Bargain Stocks to Buy on the Dip ↗

June 17, 2023

These stocks should be poised to rebound.

Via The Motley Fool

Why Teva Pharmaceutical Stock Is Jumping Today ↗

May 18, 2023

Investors are reacting positively to Teva's new growth strategy.

Via The Motley Fool

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

July 24, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

July 24, 2023

From Alvotech

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

July 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 ↗

July 06, 2023

Via Benzinga

Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023

July 05, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit ↗

July 05, 2023

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.

Via Benzinga

Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine

June 30, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Geopolitical Risks Prevail ↗

June 27, 2023

A discussion about current geopolitical risks and their impact on commodity and stock markets.

Via Talk Markets

ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity ↗

June 21, 2023

The supply of an alternative to Adderall, Vyvanse (lisdexamfetamine), a commonly used medication for Attention-deficit/hyperactivity disorder (ADHD), is dwindling, further limiting options for patients...

Via Benzinga

Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY® (fremanezumab-vfrm) Injection Significantly Reduced Migraine and Depression Symptoms in Patients

June 15, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Reaches Agreement With Kentucky to Settle the State’s Price Fixing Claims

June 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape ↗

June 12, 2023

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...

Via Benzinga

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Alvotech

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

Is AbbVie or Amgen the Better Bargain Buy Right Now? ↗

June 08, 2023

These elite drugmakers are both working through a number of headwinds.

Via The Motley Fool

Teva Concludes Nationwide Opioids Settlement Agreement

June 08, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

June 06, 2023

From Phil Inc.

Via Business Wire

Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? ↗

June 05, 2023

It's unclear whether the pivot will be enough to halt its recent decline.

Via The Motley Fool

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023

June 02, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023 ↗

May 25, 2023

Via Benzinga

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting

May 20, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.